Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Radical directions in Parkinson's disease

Transplantation of fetal mesencephalic tissue into patients suffering from Parkinson's disease has had mixed clinical results. Perhaps antioxidant therapy can increase the odds of success (pages 226–231).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Freed, W.J. Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials. Restor. Neurol. Neurosci. 3, 109–134 (1991).

    CAS  PubMed  Google Scholar 

  2. Brundin, P. & Lindvall, O. Transplantation in Parkinson's disease. In Basic and Clinical Aspects of Neuroscience (ed. Lindvall, O.) 5, 5–17 (Springer-Verlag, Berlin, 1993).

    Google Scholar 

  3. Widner, H. et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). New EnSl. J. Med. 327, 1556–1563 (1992).

    Article  CAS  Google Scholar 

  4. Nakao, N. et al. Overexpressing Cu/Zn-superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med. 1, 226–231 (1995).

    Article  CAS  Google Scholar 

  5. Epstein, C.J. et al. Transgenic mice with increased CuZn-superoxide dismutase activity: An animal model of dosage effects in Down syndrome. Proc. natl. Acad. Sci. U.S.A. 84, 8044–8048 (1987).

    Article  CAS  Google Scholar 

  6. Olanow, C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439–444 (1993).

    Article  CAS  Google Scholar 

  7. Nakao, N., Frodl, E.M., Duan, W.-M., Widner, H. & Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopaminergic neurons. Proc. natl. Acad. Sci. USA. 91, 12408–12412 (1994).

    Article  CAS  Google Scholar 

  8. Braughler, J.M. et al. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. biol. Chem. 262, 10438–10440 (1987).

    CAS  PubMed  Google Scholar 

  9. Pechan, P.A., Chowdhury, K. & Seifert, W. Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. NeuroReport 3, 469–472 (1992).

    Article  CAS  Google Scholar 

  10. Mayer, E., Fawcett, J.W. & Dunnett, S.B. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. II. Effects on nigral transplants in vivo . Neuroscience 56, 389–398 (1993).

    Article  CAS  Google Scholar 

  11. Takayama, H. et al. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1, 53–58 (1995).

    Article  CAS  Google Scholar 

  12. Mattson, M.P., Murrain, M., Guthrie, P.B. & Kater, S.B. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9, 3728–3740 (1989).

    Article  CAS  Google Scholar 

  13. Mattson, M.P., Keshava, K.N., Wang, H., Cheng, B. & Michaelis, E.K. Basic FGF regulates expression of functional 71 kDa NMDA receptor protein that mediates calcium influx & neurotoxicity in hippocampal neurons. J. Neurosci. 13, 4575–4588 (1993).

    Article  CAS  Google Scholar 

  14. The Parkinson's Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. New Engl. J. Med. 328, 176–183 (1993).

  15. Spina, M.B., Squinto, S.P., Miller, J., Lindsay, R.M. & Hyman, C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxy-dopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99–106 (1992).

    Article  CAS  Google Scholar 

  16. Beck, K.D. et al. Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium. Neurodegeneration 1, 27–36 (1992).

    Google Scholar 

  17. Lin, L.-F., Doherty, D., Lile, J., Bektesh, S. & Collins, F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–1132 (1993).

    Article  CAS  Google Scholar 

  18. Tomac, A. et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo . Nature 373, 335–339 (1995).

    Article  CAS  Google Scholar 

  19. Beck, K.D. et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339–341 (1995).

    Article  CAS  Google Scholar 

  20. Olson, L. et al. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J. neural Trans. 4, 79–95 (1992).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fisher, L., Gage, F. Radical directions in Parkinson's disease. Nat Med 1, 201–203 (1995). https://doi.org/10.1038/nm0395-201

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0395-201

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing